Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists

The Pharmacogenomics Journal volume 21, pages 78–84 (2021)Cite this article

Subjects

Abstract

Over the past decade, pharmacogenetics (PGx) became an essential tool for personalized medicine although its clinical implementation is still limited. We aimed to assess the current level of knowledge, applications, and expectations of Flemish pharmacists and physicians towards PGx and determine the factors that influence healthcare professionals’ knowledge of PGx, aiming to guide future implementation initiatives. A web-based cross-sectional survey was conducted from 8 March 2019 to 8 April 2019, targeting pharmacists, physicians, and trainees of both professions. Ten questions were used to assess the participants’ knowledge about PGx. Multivariable linear regression was used to assess the association of profession, experience, practice setting, and prior education with the level of PGx knowledge. In total, 201 Flemish healthcare providers participated, including 100 pharmacists, 73 physicians, and 28 trainees. The majority (78%) of participants were unfamiliar with the basic principles of PGx and its application in clinical practice. The mean percentage of correct answers achieved for the knowledge assessment questions was 34%. Only 9% had counseled patients, while 8% assisted other healthcare professionals on PGx tests the past year. Participants’ PGx knowledge was significantly affected by their profession, practice setting, and level of prior education independent of years of experience. These findings provide insight into factors affecting the knowledge of PGx and the current level of PGx implementation in Flemish clinical practice. This may form a basis for developing educational initiatives to enhance the clinical application of PGx in Flanders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pharmacogenetic knowledge scores stratified by profession, practice setting, education and experience.

Similar content being viewed by others

References

  1. Stewart A, Brice P, Burton H, Pharoah P, Sanderson S, Zimmern R. Genetics, Health Care and Public Policy: An Introduction to Public Health Genetics. Cambridge University Press, Cambridge; 2007.

  2. Haga SB, Burke W, Ginsburg GS, Mills R, Agans R. Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin Genet. 2012;82:388–94.

    Article  CAS  Google Scholar 

  3. Ingelman-Sundberg M, Rodriguez-Antona C. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Philos Trans R Soc Lond Ser B, Biol Sci. 2005;360:1563–70.

    Article  CAS  Google Scholar 

  4. Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharm Pharmacother. 2013;4:S73–7.

    Article  Google Scholar 

  5. MacKenzie M, Hall R. Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. Can J Anaesth. 2017;64:45–64.

    Article  Google Scholar 

  6. Evans WE, McLeod HL. Pharmacogenomics–drug disposition, drug targets, and side effects. N. Engl J Med. 2003;348:538–49.

    Article  CAS  Google Scholar 

  7. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004;429:464–8.

    Article  CAS  Google Scholar 

  8. Kudzi W, Adjei GO, Ofori-Adjei D, Dodoo AN. Pharmacogenetics in Ghana: reviewing the evidence. Ghana Med J. 2011;45:73–80.

    Article  CAS  Google Scholar 

  9. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. Chapter Four—G6PD deficiency: global distribution, genetic variants and primaquine therapy. In: Hay SI, Price R, Baird JK, editors. Advances in Parasitology. 81: Academic Press, United Kingdom; 2013. pp. 133–201.

  10. Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL. Polymorphic hydroxylation of debrisoquine in man. Lancet. 1977;310:584–6.

    Article  Google Scholar 

  11. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988;331:442–6.

    Article  CAS  Google Scholar 

  12. Wheeler DA, Wang L. From human genome to cancer genome: the first decade. Genome Res. 2013;23:1054–62.

    Article  CAS  Google Scholar 

  13. Makalowski W. The human genome structure and organization. Acta Biochim Pol. 2001;48:587–98.

    Article  CAS  Google Scholar 

  14. Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm. 2009;66:625–37.

    Article  CAS  Google Scholar 

  15. Owen RP, Sangkuhl K, Klein TE, Altman RB. Cytochrome P450 2D6. Pharmacogenet Genomics 2009;19:559–62.

    Article  CAS  Google Scholar 

  16. Barbarino JM, Kroetz DL, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for human leukocyte antigen B. Pharmacogenet Genomics. 2015;25:205–21.

    Article  CAS  Google Scholar 

  17. Scott SA, Sangkuhl K, Shuldiner AR, Hulot JS, Thorn CF, Altman RB, et al. PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. Pharmacogenet Genomics. 2012;22:159–65.

    Article  CAS  Google Scholar 

  18. Weitendorf F, Reynolds KK. The pharmacist’s perspective on pharmacogenetics implementation. Clin Lab Med. 2016;36:543–56.

    Article  Google Scholar 

  19. van der Wouden CH, Cambon-Thomsen A, Cecchin E, Cheung KC, Davila-Fajardo CL, Deneer VH, et al. Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharm Ther. 2017;101:341–58.

    Article  Google Scholar 

  20. Drozda K, Pacanowski MA, Grimstein C, Zineh I. Pharmacogenetic labeling of FDA-approved drugs: a regulatory retrospective. JACC Basic Transl Sci. 2018;3:545–9.

    Article  Google Scholar 

  21. Albassam A, Alshammari S, Ouda G, Koshy S, Awad A. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait. PLoS ONE. 2018;13:e0203033.

    Article  Google Scholar 

  22. Cecchin E, Roncato R, Guchelaar HJ, Toffoli G. Ubiquitous pharmacogenomics (U-PGx): the time for implementation is now. an Horizon2020 Program to drive pharmacogenomics into clinical practice. Curr Pharm Biotechnol. 2017;18:204–9.

    Article  CAS  Google Scholar 

  23. Bank PCD, Swen JJ, Guchelaar H-J. A nationwide survey of pharmacists’ perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. Pharmacogenomics 2017;18:215–25.

    Article  CAS  Google Scholar 

  24. AlEjielat R, Ejielat Z, Andrawes S, Mhaidat NM. An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists. Personalized Med. 2016;13:143–54.

    Article  CAS  Google Scholar 

  25. Schwartz EJ, Issa AM. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine. Per Med. 2017;14:27–35. https://doi.org/10.2217/pme-2016-0063.

  26. Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Personalized Med. 2013;10:793–800.

    Article  CAS  Google Scholar 

  27. Bannur Z, Bahaman S, Salleh M, Kek TL. Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. Int Med J Malays. 2014;13:41–50.

    Google Scholar 

  28. Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Personalized Med. 2012;9:1927.

    Article  Google Scholar 

  29. Abou Diwan E, Zeitoun RI, Abou Haidar L, Cascorbi I, Khoueiry Zgheib N. Implementation and obstacles of pharmacogenetics in clinical practice: An international survey. Br J Clin Pharmacol. 2019;85:2076–88. https://doi.org/10.1111/bcp.13999.

  30. Stanek EJ, Sanders CL, Taber KAJ, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US Physicians: Results of a Nationwide Survey. Clin Pharmacol Ther. 2012;91:450–8. https://doi.org/10.1038/clpt.2011.306.

  31. Kadafour M, Haugh R, Posin M, Kayser S, Shin J Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics. 2009;10:1853–60. https://doi.org/10.2217/pgs.09.117.

  32. OECD. Health Care Resources: Pharmacists 2019. Accessed 13 Sep 2019. https://stats.oecd.org/index.aspx?queryid=30178#.

  33. EAHP. Belgian Association of Hospital Pharmacists 2012. Accessed 13 Sep 2019. https://www.eahp.eu/members/belgium.

Download references

Acknowledgements

We thank the participants for their time in filling our survey.

Author information

Authors and Affiliations

  1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium

    Ahmed Edris, Anna Vanoverschelde, Pranvera Bushaj & Lies Lahousse

  2. Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium

    Filip Van Nieuwerburgh

Authors
  1. Ahmed Edris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Vanoverschelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pranvera Bushaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filip Van Nieuwerburgh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lies Lahousse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lies Lahousse.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edris, A., Vanoverschelde, A., Bushaj, P. et al. Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists. Pharmacogenomics J 21, 78–84 (2021). https://doi.org/10.1038/s41397-020-00180-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41397-020-00180-x

Search

Advanced search

Quick links